- Home
- Publications
- Publication Search
- Publication Details
Title
A Bivalent Omicron-Containing Booster Vaccine against Covid-19
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 387, Issue 14, Pages 1279-1291
Publisher
Massachusetts Medical Society
Online
2022-09-17
DOI
10.1056/nejmoa2208343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
- (2022) Hung Fu Tseng et al. NATURE MEDICINE
- SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
- (2022) Rolando Pajon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- (2022) Jill M. Ferdinands et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- (2022) Mark G. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
- (2022) Rahul K. Suryawanshi et al. NATURE
- Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial
- (2022) Laurence Chu et al. NATURE MEDICINE
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
- (2022) Juliet R. C. Pulliam et al. SCIENCE
- Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
- (2022) Juanjie Tang et al. Nature Communications
- Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
- (2022) Namrata Prasad et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
- (2021) Hana M. El Sahly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
- (2021) Amarendra Pegu et al. SCIENCE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now